Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure
暂无分享,去创建一个
G. Nakazawa | S. Matsumoto | K. Sakai | N. Nakamura | T. Murakami | Makoto Natsumeda | N. Shinozaki | Y. Ohno | Y. Ikari | Katsuaki Sakai
[1] Timothy M. Markman,et al. Improvement in tricuspid regurgitation following catheter ablation of atrial fibrillation , 2020, Journal of cardiovascular electrophysiology.
[2] B. Prendergast,et al. Mitral regurgitation in heart failure: time for a rethink. , 2019, European heart journal.
[3] V. Nkomo,et al. Characteristics and treatment strategies for severe tricuspid regurgitation , 2019, Heart.
[4] A. Sannino,et al. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials. , 2019, JACC. Cardiovascular imaging.
[5] T. Imamura,et al. Update of acute and long-term tolvaptan therapy. , 2019, Journal of cardiology.
[6] P. Voisine,et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. , 2019, The New England journal of medicine.
[7] T. Muramatsu,et al. A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan , 2018, PloS one.
[8] Y. Kawai,et al. Right ventricular enlargement predicts responsiveness to tolvaptan in congestive heart failure patients with reduced ejection fraction , 2018, International journal of cardiology. Heart & vasculature.
[9] Li Jiang,et al. Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study , 2018, American Journal of Cardiovascular Drugs.
[10] D. Maucort-Boulch,et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation , 2018, The New England journal of medicine.
[11] J. Navia,et al. Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions. , 2018, Journal of the American College of Cardiology.
[12] H. Takashima,et al. Impact of Continuous Administration of Tolvaptan on Preventing Medium-Term Worsening Renal Function and Long-Term Adverse Events in Heart Failure Patients with Chronic Kidney Disease. , 2018, International heart journal.
[13] K. Kinugawa,et al. Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics. , 2018, International heart journal.
[14] V. Miller,et al. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. , 2017, Journal of the American College of Cardiology.
[15] T. Murohara,et al. Safety and Efficacy of Long-Term Use of Tolvaptan in Patients With Heart Failure and Chronic Kidney Disease. , 2017, Circulation journal : official journal of the Japanese Circulation Society.
[16] Yuchi Han,et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[17] R. Siegel,et al. Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study. , 2017, Circulation. Cardiovascular imaging.
[18] M. Endo,et al. Tricuspid surgery for tricuspid regurgitation: review , 2016, General Thoracic and Cardiovascular Surgery.
[19] K. Sugi,et al. Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction. , 2016, Journal of cardiac failure.
[20] J. Piccini,et al. Atrial fibrillation in heart failure: what should we do? , 2015, European heart journal.
[21] M. Tsutsumi,et al. Efficacy And Safety of Coadministration of Tolvaptan And Carperitide for Acute Decompensated Heart Failure Patients , 2015 .
[22] M. Humbert,et al. Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension , 2015, European Respiratory Journal.
[23] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.
[24] Y. Shibagaki,et al. Efficacy of Tolvaptan Added to Furosemide in Heart Failure Patients with Advanced Kidney Dysfunction: A Pharmacokinetic and Pharmacodynamic Study , 2015, Clinical Pharmacokinetics.
[25] M. O'Neill,et al. Catheter ablation of atrial fibrillation in heart failure. , 2013, Heart failure clinics.
[26] L. A. Bonet,et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[27] M. Keane,et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. , 2011, Journal of the American College of Cardiology.
[28] J. Brugada,et al. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. , 2009, The American journal of cardiology.
[29] G. Fonarow,et al. Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.
[30] J. Ouyang,et al. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. , 2006, American journal of physiology. Renal physiology.
[31] John Gorcsan,et al. Echocardiography and Resynchronization A Mechanism for Immediate Reduction in Mitral Regurgitation After Cardiac Resynchronization Therapy Insights From Mechanical Activation Strain Mapping , 2004 .
[32] Jayant Nath,et al. Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.
[33] J. Almeida. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. , 1999, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.